The specific objectives of the Clinical Research Support Services (CRSS) Core are: ? To increase the quality and quantity of investigator-initiated clinical trials and facilitate the translational research efforts of the Cancer Center by providing assistance in protocol development, implementation and data capture. ? To increase the quality and quantity of grants and protocols in population research of the Cancer Center by providing assistance in study design, development of survey tools and recruitment. ? To provide a central core of personnel with expertise in all types of clinical trials management: regulatory;compliance, medical editing, and data management for investigator-initiated clinical intervention trials in cancer prevention, early detection and treatment and observational or epidemiology research relevant to cancer. ? To train and educate clinical research coordinators (data managers and nurses) in clinical intervention trials. ? To train and educate data managers and staff who conduct population-based research. ? To perform internal audits for data and safety monitoring. ? To increase the participation of subjects in clinical trials, with emphasis on diversity. ? -To provide a web-based protocol/data management system for all types of studies. ? To provide the infrastructure for the reporting requirements designated by the NCI. The Clinical Research Support Services Core serves four UCSF campuses: the in-patient and out-patient facilities at Mt. Zion and Parnassus, San Francisco General Hospital and San Francisco Veterans Administration Medical Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082103-11
Application #
7886670
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
11
Fiscal Year
2009
Total Cost
$815,903
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Olshen, Adam; Wolf, Denise; Jones, Ella F et al. (2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham) 5:011014
Li, Megan; Kroetz, Deanna L (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 182:152-160
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u
Cobler, Lara; Zhang, Hui; Suri, Poojan et al. (2018) xCT inhibition sensitizes tumors to ?-radiation via glutathione reduction. Oncotarget 9:32280-32297
Li, Megan; Mulkey, Flora; Jiang, Chen et al. (2018) Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 24:4734-4744
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19:1212-1223
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28
Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSUREā„¢). Prostate 78:32-39
Guydish, Joseph; Tajima, Barbara; Le, Thao et al. (2018) Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control 27:43-49

Showing the most recent 10 out of 192 publications